The Centers for Medicare & Medicaid Services has announced an error in calculating Clostridium difficile infection performance during the first two quarters of 2014.

This error affects hospital performance in the fiscal year 2017 Hospital Acquired Condition Reduction Program, baseline performance in the FY 2018 hospital value-based purchasing program, and measure data reported on Hospital Compare in 2015.

As a result, CMS is conducting a second review and corrections period for the FY 2017 HAC program from today through Sept. 30 to allow hospitals to review their updated C Difficile performance.

CMS also has updated the baseline period performance standard for the FY 2018 VBP program, and intends to update the archived databases of Hospital Compare to reflect corrected performance data.

For more information, see .

Related News Articles

Headline
The AHA Aug. 7 launched a new webpage, Reducing Disparities in Health Outcomes, featuring new and familiar resources for members and their communities. As part…
Headline
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-…
Headline
Kindergarten vaccination rates declined during the 2024-25 school year, according to data released July 31 by the Centers for Disease Control and Prevention.…
Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for…
Headline
Five pediatric flu deaths were reported to the Centers for Disease Control and Prevention last week, pushing the total to 266 for the 2024-2025 flu season,…
Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people…